abstract |
The present invention provides a pharmaceutical composition for treating an autoimmune disease, comprising an acceptable pharmaceutical carrier and an agent capable of activating regulatory CD4 + CD25 + T cells, wherein the composition is to be administered to a subject at a dose of the agent from 0.2 mg to 30 mg |